Power of Partnership: Finding the Right Provider to Streamline 세포주 Development
For biotech companies, finding the right partner for 세포주 development is essential to producing effective, high-quality target proteins.
In this webinar, learn more about SpikImm’s 단일클론항체 therapy targeting COVID-19 infection, and how the biotech partnered with 싸토리우스 to streamline 세포주 development and accelerate time to market.
Watch Now
Review key considerations for selecting a CLD partner, including extensive experience and availability of state-of-the-art facilities.
Learn how media considerations play a key role in 세포주 development.
Discover how a producer of 단일클론항체-based therapies partnered with a CLD service provider to accelerate commercialization.
Jérôme Tiollier has more than 30 years of pharmaceutical R&D experience in various senior leadership positions, helping to develop first-in-class products for Imedex, Imtix Sangstat, and Innate Pharma. He has managed multiple areas of drug development, including CMC toxicology, PK, drug nonclinical demonstration, translational scientific research, and early-phase clinical and regulatory operations.
Sandrine Chevalier has worked for 싸토리우스 since 2021 as Regional Marketing Manager EMEA for 세포주, Media and Testing Solutions. She has more than 15 years’ experience in the pharma and biotech industries, where she has held various Product and Marketing and Business Manager roles. She has a master’s degree in Cellular and Molecular Biology and Oncology and an MBA in Pharmaceutical Management.
Lisa Blaschke has been working for 싸토리우스 since 2017 in various roles. She earned her phD in the field of technical biology from the University of Stuttgart, Germany, and started her career as an 어플리케이션 Specialist for CLD services at 싸토리우스. In this role, she was responsible for technical client conversations, scoping out their CLD projects and ensuring clients’ needs are met. In 2020, Lisa was assigned a project leader, where she led various projects focused on launching new cell lines and cell culture media products. Since April 2022, she is now driving forward the strategic development of 싸토리우스’ CHO 세포주 development portfolio.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.